Skip to Content

Vanectyl-P (Canada)

This page contains information on Vanectyl-P for veterinary use.
The information provided typically includes the following:
  • Vanectyl-P Indications
  • Warnings and cautions for Vanectyl-P
  • Direction and dosage information for Vanectyl-P

Vanectyl-P

This treatment applies to the following species:
Manufacturer: Zoetis

trimeprazine tartrate and prednisolone tablets

DIN 00170925

Veterinary Use Only

antipruritic / anti-inflammatory

for dogs

Medicinal Ingredients: Trimeprazine tartrate 5 mg, and prednisolone 2 mg, per tablet

Vanectyl-P Indications

For the relief of itching and inflammation in canine skin disorders such as dry or moist eczema, non-specific dermatitis, otitis externa and fungus infections.

Dosage and Administration

Administer orally per body weight, the following doses: 1/2 tablet up to 5 kg, 1 tablet from 5 to 10 kg, 2 tablets from 10 to 20 kg, and 3 tablets for over 20 kg, twice daily for the first 4 days, then once daily until the animal is asymptomatic.

Continuous medication with this drug for more than 10 days is not recommended unless supervised by a veterinarian.

Warnings

Keep out of reach of children.

Storage

Store between 15 and 25°C.

Zoetis and Vanectyl are trademarks of Zoetis or its licensors, used under license by Zoetis Canada Inc.

Zoetis Canada Inc., Kirkland QC H9H 4M7

Net

 

500 tablets

7538-05-3

30421500

NAC No.: 1198108.4

ZOETIS CANADA
16,740 TRANS-CANADA HIGHWAY, KIRKLAND, QC, H9H 4M7
Order Desk:   800-663-8888
Technical Services Canada:   800-461-0917
Technical Services USA:   800-366-5288
Website:   www.zoetis.ca
Every effort has been made to ensure the accuracy of the Vanectyl-P information published above. However, it remains the responsibility of the readers to familiarize themselves with the product information contained on the Canadian product label or package insert.

Copyright © 2015 North American Compendiums. Updated: 2015-04-03

(web4)